PNC-27
to clear
How a single dose clears, assuming first-order elimination. The half-life is the biggest driver of how often you dose — start a cycle to see your own cumulative concentration curve.
A research peptide studied in vitro for selectively destroying cancer cells. Purely experimental — no human efficacy or safety data.
Contains an HDM-2-binding domain plus a membrane-penetrating sequence that forms pores selectively in cancer-cell membranes in lab models.
Laboratory research only; no established human protocol.
Reconstituted: refrigerated; protect from light.
This page summarizes publicly available information. None of it constitutes medical advice, prescription, or recommendation to acquire, possess, or use any compound. Many peptides described are research chemicals not approved for human use in the EU. Consult a licensed physician.
BPC-157
A synthetic pentadecapeptide derived from a protein in gastric juice. Widely used for tendon, ligament, and gut healing. Strong animal-model evidence, limited human RCTs.
TB-500
A synthetic fragment of Thymosin Beta-4, a protein involved in cell migration, differentiation, and tissue repair.
Thymosin α1
An immunomodulatory peptide approved in many countries for chronic hepatitis B and as a cancer adjuvant; used off-label for immune support.